|
Oct 8
|
Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping
|
|
Jul 25
|
Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven
|
|
Jun 13
|
Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders
|
|
Jun 12
|
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
|
|
May 6
|
Precipio Secures a short-term $500K Credit Facility
|
|
Mar 25
|
Precipio Announces Year end 2023 Shareholder Update Call
|
|
Aug 10
|
Precipio Announces Q2-2023 Shareholder Update Call
|
|
Aug 8
|
Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel
|